Successful Treatment of Refractory Cutaneous Manifestations of Dermatomyositis With Intravenous Immunoglobulin: A Case Report

被引:0
|
作者
Aldoseri, Yousif B. [1 ]
Saad, Sahar [2 ]
Aldoseri, Khalid B. [1 ]
机构
[1] King Hamad Univ Hosp, Internal Med, Busaiteen, Bahrain
[2] King Hamad Univ Hosp, Rheumatol, Busaiteen, Bahrain
关键词
steroid refractory; skin lesions; refractory disease; intravenous immunoglobulins (ivig); adult-onset dermatomyositis;
D O I
10.7759/cureus.68518
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dermatomyositis is a connective tissue disorder with dermatological and extracutaneous manifestations. Multiple treatment modalities have been used to treat dermatomyositis, and there have been cases with resistant disease refractory to conventional therapies. Corticosteroids are usually used to achieve remission, and from then, steroid-sparing agents such as azathioprine are used to maintain remission. However, in this report, we present a case of dermatomyositis with refractory cutaneous manifestation. The patient's muscular pain had subsided with the use of corticosteroids, but the dermatological lesions did not respond to multiple treatment modalities, responding only to intravenous immunoglobulins (IVIG).
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Intravenous immunoglobulin for treatment of refractory cutaneous manifestations of dermatomyositis
    Li, Yumeng
    Galimberti, Fabrizio
    Fernandez, Anthony
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB81 - AB81
  • [2] Intravenous immunoglobulin is an effective treatment for refractory cutaneous dermatomyositis
    Galimberti, F.
    Kooistra, L.
    Li, Y.
    Chatterjee, S.
    Fernandez, A. P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (08) : 906 - 912
  • [3] Intravenous immunoglobulin is an effective treatment for refractory cutaneous dermatomyositis
    Galimberti, F.
    Kooistra, L.
    Li, Y.
    Chatterjee, S.
    Fernandez, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S92 - S92
  • [4] Successful treatment of cutaneous lesions in juvenile dermatomyositis with high-dose intravenous immunoglobulin
    Amano, H.
    Nagai, Y.
    Katada, K.
    Hashimoto, C.
    Ishikawa, O.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (06) : 1390 - 1392
  • [5] Treatment of refractory cutaneous dermatomyositis: an academic medical center's experience with intravenous immunoglobulin
    Femia, Alisa N.
    Eastham, A. Brooke
    Lam, Christina
    Liu, Stephanie W.
    Townsend, Henry B.
    Merola, Joseph F.
    Qureshi, Abrar A.
    Vleugels, Ruth Ann
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (06) : 1694 - 1694
  • [6] Successful treatment with baricitinib in a patient with refractory cutaneous dermatomyositis
    Delvino, Paolo
    Bartoletti, Alice
    Monti, Sara
    Biglia, Alessandro
    Montecucco, Carlomaurizio
    Carducci, Mauro
    Ripamonti, Giorgio
    Cavagna, Lorenzo
    RHEUMATOLOGY, 2020, 59 (12) : E125 - E127
  • [7] SUCCESSFUL TREATMENT OF DERMATOMYOSITIS WITH HIGH-DOSE INTRAVENOUS 7S IMMUNOGLOBULIN - A CASE-REPORT
    ZIFKO, U
    GRISOLD, W
    WIENER KLINISCHE WOCHENSCHRIFT, 1995, 107 (17) : 522 - 524
  • [8] Successful treatment of dermatomyositis during pregnancy with intravenous immunoglobulin monotherapy
    Williams, Lloyd
    Chang, Peter Y.
    Park, Ellen
    Gorson, Kenneth C.
    Bayer-Zwirello, Lucy
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (02): : 561 - 563
  • [9] Successful treatment of dermatomyositis with high-dose intravenous immunoglobulin
    Kuwano, Y
    Ihn, H
    Yazawa, N
    Kakinuma, T
    Asahina, A
    Kikuchi, K
    Tamaki, K
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (02) : 158 - 159
  • [10] REFRACTORY AND SEVERE CUTANEOUS CHANGES DURING DERMATOMYOSITIS - UTILITY OF THE INTRAVENOUS IMMUNOGLOBULIN THERAPY
    CASTANET, J
    LACOUR, JP
    ORTONNE, JP
    REVUE DE MEDECINE INTERNE, 1993, 14 (07): : 737 - 737